首页|期刊导航|Medicine Plus|Perspective to clinical translation of radiotherapy-activated prodrugs:challenges and advances

Perspective to clinical translation of radiotherapy-activated prodrugs:challenges and advances

Qiang Wei Simiao Qiao Qunfeng Fu Zhibo Liu

Medicine Plus2025，Vol.2Issue(2)：P.1-7,7.

Medicine Plus2025，Vol.2Issue(2)：P.1-7,7.DOI:10.1016/j.medp.2025.100076

Perspective to clinical translation of radiotherapy-activated prodrugs:challenges and advances

Qiang Wei ¹Simiao Qiao ¹Qunfeng Fu ²Zhibo Liu³

作者信息

1. Changping Laboratory,Beijing 102206,China
2. Department of Radiology,Molecular Imaging Program at Stanford,Stanford Medicine,Stanford,CA 94305,USA
3. Changping Laboratory,Beijing 102206,China Beijing National Laboratory for Molecular Sciences,Radiochemistry and Radiation Chemistry Key Laboratory of Fundamental Science,Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education,College of Chemistry and Molecular Engineering,Peking University,Beijing 100871,China Peking University-Tsinghua University Center for Life Sciences,Peking University,Beijing 100871,China Key Laboratory of Carcinogenesis and Translational Research,Ministry of Education,NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals(National Medical Products Administration),Department of Nuclear Medicine,Peking University Cancer Hospital&Institute,Beijing 100142,China
折叠

摘要

关键词

clinical translation/radiotherapy activated prodrugs/cancer treatment

分类

医药卫生

引用本文复制引用

Qiang Wei,Simiao Qiao,Qunfeng Fu,Zhibo Liu..Perspective to clinical translation of radiotherapy-activated prodrugs:challenges and advances[J].Medicine Plus,2025,2(2):P.1-7,7.

基金项目

supported by the Ministry of Science and Technology of the People’s Republic of China(2021YFA1601400) （2021YFA1601400）

the National Natural Science Foundation of China(22225603) （22225603）

the Beijing Municipal Natural Science Foundation(Z200018) （Z200018）

Changping Laboratory. （）

Medicine Plus

ISSN：2097-289X

访问量1

下载量0

段落导航